About Eikon Therapeutics
Operator of a drug discovery and development platform intended to offer a novel treatment for life-threatening diseases.
Open positions (3)
Company details
Funding
Total raised
$1.2B
Last stage
Series D
Investors
Founders
Xavier Darzacq
Served as interim CTO during the company's first year; scientist involved in live-cell imaging research.
LinkedInEric Betzig
Nobel Prize-winning physicist (Chemistry, 2014) and UC Berkeley scientist who pioneered super-resolution fluorescence microscopy.
Robert Tjian
Biochemist at the University of California, Berkeley and former President of the Howard Hughes Medical Institute.
Luke Lavis
Researcher known for contributions to fluorescent dye chemistry and single-molecule imaging technologies used in Eikon's discovery platform.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.